Ultra Clean Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ultra Clean Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 29, 2023 | $1.73B | Mar 6, 2024 |
| FY2023 | Dec 30, 2022 | $2.37B | Mar 6, 2024 |
| FY2020 | Dec 31, 2021 | $2.10B | Mar 1, 2022 |
| FY2020 | Dec 25, 2020 | $369.60M | Feb 23, 2021 |
| FY2020 | Sep 25, 2020 | $363.30M | Feb 23, 2021 |
| FY2020 | Jun 26, 2020 | $344.80M | Feb 23, 2021 |
| FY2020 | Mar 27, 2020 | $320.90M | Feb 23, 2021 |
| FY2020 | Dec 27, 2019 | $286.40M | Feb 23, 2021 |
| FY2020 | Sep 27, 2019 | $254.30M | Feb 23, 2021 |
| FY2020 | Jun 28, 2019 | $265.40M | Feb 23, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 27, 2024 | $2.10B | Feb 25, 2025 |
| FY2024 | Dec 29, 2023 | $1.73B | Feb 25, 2025 |
| FY2024 | Dec 30, 2022 | $2.37B | Feb 25, 2025 |
| FY2020 | Dec 31, 2021 | $2.10B | Mar 1, 2022 |
| FY2022 | Dec 25, 2020 | $1.40B | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | $1.07B | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | $1.10B | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | $924.40M | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | $562.76M | Mar 22, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 29, 2017 | $924.35M | Mar 14, 2018 |
| FY2017 | Dec 30, 2016 | $562.76M | Mar 14, 2018 |
| FY2017 | Dec 25, 2015 | $469.10M | Mar 14, 2018 |
| FY2016 | Dec 26, 2014 | $513.96M | Mar 15, 2017 |
| FY2015 | Dec 27, 2013 | $444.02M | Mar 9, 2016 |
| FY2012 | Dec 28, 2012 | $90.07M | Mar 14, 2013 |
| FY2012 | Sep 30, 2012 | $100.85M | Mar 14, 2013 |
| FY2012 | Jun 29, 2012 | $101.95M | Mar 14, 2013 |
| FY2012 | Mar 31, 2012 | $110.57M | Mar 14, 2013 |
| FY2012 | Dec 30, 2011 | $86.87M | Mar 14, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $322.90M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $356.30M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | $277.30M | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $465.00M | Feb 25, 2025 |
| FY2020 | Dec 31, 2021 | $430.00M | Mar 1, 2022 |
| FY2020 | Dec 25, 2020 | $77.60M | Feb 23, 2021 |
| FY2020 | Sep 25, 2020 | $74.60M | Feb 23, 2021 |
| FY2020 | Jun 26, 2020 | $73.90M | Feb 23, 2021 |
| FY2020 | Mar 27, 2020 | $65.70M | Feb 23, 2021 |
| FY2020 | Dec 27, 2019 | $56.30M | Feb 23, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | ($181.20M) | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $23.70M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | ($31.10M) | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $40.40M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $119.50M | Mar 6, 2024 |
| FY2020 | Dec 25, 2020 | $22.50M | Feb 23, 2021 |
| FY2020 | Sep 25, 2020 | $24.40M | Feb 23, 2021 |
| FY2020 | Jun 26, 2020 | $21.30M | Feb 23, 2021 |
| FY2020 | Mar 27, 2020 | $9.40M | Feb 23, 2021 |
| FY2020 | Dec 27, 2019 | ($10.30M) | Feb 23, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | ($107.40M) | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $91.20M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | $35.20M | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $120.40M | Feb 25, 2025 |
| FY2020 | Dec 31, 2021 | $185.70M | Mar 1, 2022 |
| FY2022 | Dec 25, 2020 | $121.40M | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | $29.90M | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | $60.70M | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | $89.50M | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | $22.39M | Mar 22, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $32.00M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $28.30M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | $28.30M | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $28.50M | Feb 25, 2025 |
| FY2020 | Dec 31, 2021 | $24.50M | Mar 1, 2022 |
| FY2022 | Dec 25, 2020 | $14.80M | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | $14.60M | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | $13.30M | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | $11.70M | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | $9.90M | Mar 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $65.60M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $65.00M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | $135.90M | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $47.20M | Feb 25, 2025 |
| FY2020 | Dec 31, 2021 | $211.60M | Mar 1, 2022 |
| FY2022 | Dec 25, 2020 | $97.30M | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | $121.00M | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | $41.70M | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | $48.90M | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | $17.58M | Mar 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $50.30M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $63.50M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | $75.80M | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $100.10M | Feb 25, 2025 |
| FY2020 | Dec 31, 2021 | $59.30M | Mar 1, 2022 |
| FY2022 | Dec 25, 2020 | $36.40M | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | $26.30M | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | $26.10M | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | $16.10M | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | $7.28M | Mar 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $1.73B | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $1.92B | Feb 23, 2026 |
| FY2024 | Dec 29, 2023 | $1.87B | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | $1.96B | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | $1.87B | Mar 6, 2024 |
| FY2020 | Dec 25, 2020 | $1.10B | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | $1.02B | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | $965.50M | Mar 11, 2020 |
| FY2018 | Dec 29, 2017 | $563.41M | Mar 22, 2019 |
| FY2017 | Dec 30, 2016 | $380.70M | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $944.90M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $984.10M | Feb 23, 2026 |
| FY2024 | Dec 29, 2023 | $970.50M | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | $1.02B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.13B | Feb 28, 2023 |
| FY2020 | Dec 25, 2020 | $551.30M | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | $566.80M | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | $514.50M | Mar 11, 2020 |
| FY2018 | Dec 29, 2017 | $263.11M | Mar 22, 2019 |
| FY2017 | Dec 30, 2016 | $164.57M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $711.00M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $873.60M | Feb 23, 2026 |
| FY2024 | Dec 29, 2023 | $838.90M | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | $887.90M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $848.90M | Feb 28, 2023 |
| FY2020 | Dec 25, 2020 | $532.60M | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | $436.70M | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | $436.30M | Mar 11, 2020 |
| FY2018 | Dec 29, 2017 | $300.31M | Mar 22, 2019 |
| FY2017 | Dec 30, 2016 | $216.13M | Mar 14, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $114.20M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $265.30M | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | $265.20M | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | $248.80M | Feb 25, 2025 |
| FY2022 | Dec 31, 2021 | $270.00M | Feb 28, 2023 |
| FY2020 | Dec 25, 2020 | $171.10M | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | $171.10M | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | $150.20M | Mar 11, 2020 |
| FY2019 | Dec 29, 2017 | $85.20M | Mar 11, 2020 |
| FY2017 | Dec 30, 2016 | $85.25M | Mar 14, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $189.20M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $370.40M | Feb 23, 2026 |
| FY2024 | Dec 29, 2023 | $346.70M | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | $377.80M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $337.40M | Feb 28, 2023 |
| FY2020 | Dec 25, 2020 | $217.90M | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | $140.30M | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | $149.70M | Mar 11, 2020 |
| FY2018 | Dec 29, 2017 | $113.12M | Mar 22, 2019 |
| FY2017 | Dec 30, 2016 | $38.04M | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $311.80M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | $313.90M | Feb 23, 2026 |
| FY2024 | Dec 29, 2023 | $307.00M | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | $358.80M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $466.50M | Feb 28, 2023 |
| FY2020 | Dec 25, 2020 | $200.30M | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | $162.50M | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | $144.10M | Mar 11, 2020 |
| FY2018 | Dec 29, 2017 | $68.31M | Mar 22, 2019 |
| FY2017 | Dec 30, 2016 | $52.47M | Mar 14, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | $481.40M | Feb 23, 2026 |
| FY2024 | Dec 27, 2024 | $499.70M | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | $485.30M | Mar 6, 2024 |
| FY2020 | Dec 31, 2021 | $565.40M | Mar 1, 2022 |
| FY2020 | Dec 25, 2020 | $276.90M | Feb 23, 2021 |
| FY2019 | Dec 27, 2019 | $301.90M | Mar 11, 2020 |
| FY2013 | Dec 27, 2013 | $55.10M | Mar 12, 2014 |
| FY2012 | Dec 28, 2012 | $75.60M | Mar 14, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | (4) | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | 0 | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | 0 | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 6, 2024 |
| FY2022 | Dec 25, 2020 | 1 | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | 0 | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | 2 | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | 0 | Mar 22, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | (4) | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | 0 | Feb 23, 2026 |
| FY2025 | Dec 29, 2023 | 0 | Feb 23, 2026 |
| FY2024 | Dec 30, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 6, 2024 |
| FY2022 | Dec 25, 2020 | 1 | Feb 28, 2023 |
| FY2020 | Dec 27, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 28, 2018 | 0 | Feb 23, 2021 |
| FY2019 | Dec 29, 2017 | 2 | Mar 11, 2020 |
| FY2018 | Dec 30, 2016 | 0 | Mar 22, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 26, 2025 | 45.50M | Feb 23, 2026 |
| FY2025 | Dec 27, 2024 | 45.10M | Feb 23, 2026 |
| FY2024 | Dec 29, 2023 | 44.60M | Feb 25, 2025 |
| FY2023 | Dec 30, 2022 | 45.20M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | 44.90M | Feb 28, 2023 |
| FY2020 | Dec 25, 2020 | 40.60M | Mar 1, 2022 |
| FY2020 | Dec 27, 2019 | 39.90M | Feb 23, 2021 |
| FY2019 | Dec 28, 2018 | 39 | Mar 11, 2020 |
| FY2018 | Dec 29, 2017 | 33.66M | Mar 22, 2019 |
| FY2017 | Dec 30, 2016 | 32.96M | Mar 14, 2018 |